Skip to main content

Table 1

From: Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from Romania

Type of anaemia

Definition

Total (n=209)

Grade 1-2

Hb 9-10.9 or 2.5-4.4 g/dL decrease

33 (16%)

Grade 3-4

Hb <8.9 or >4.5 g/dL decrease

86 (41%)

D/C for anaemia

 

1 (<1%)

Anaemia as Serious AE

 

9 (4%)